Jukka Pelkonen

Turunen, A; Silvennoinen, R; Partanen, A; Valtola, J; Siitonen, T; Putkonen, M; Sankelo, M; Pyörälä, M; Kuittinen, T; Penttilä, K; Sikiö, A; Savolainen, ER; Mäntymaa, P; Pelkonen, J; Varmavuo,V; Jantunen, E. 2021. Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study Transfusion 61 6: 1830-1844. 2021

Partanen, Anu; Turunen, Antti; Valtola, Jaakko; Vasala, Kaija; Ågren, Lasse; Penttilä, Karri; Pyörälä, Marja; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2020. A prospective comparison of pegfilgrastim and lipegfilgrastim combined with chemotherapy in the mobilization of CD34+ cells in NHL patients Journal of clinical apheresis 35 4: 255-263. 2020

Turunen, Antti; Valtola, Jaakko; Partanen, Anu; Ropponen, Antti; Kuittinen, Outi; Kuitunen, Hanne; Vasala, Kaija; Ågren, Lasse; Penttilä, Karri; Keskinen, Leena; Savolainen, Eeva-Riitta; Pyörälä, Marja; Kuittinen, Taru; Selander, Tuomas; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2020. Autograft cellular composition and outcome in NHL patients: results of the prospective multicenter GOA study Leukemia & lymphoma 61 9: 2082-2092. 2020

Jantunen, Esa; Valtola, Jaakko; Partanen, Anu; Turunen, Antti; Kuittinen, Taru; Silvennoinen, Raija; Pyörälä, Marja; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville. 2020. Pleriksafori kantasolujen mobilisaatiossa autologista siirtoa varten Duodecim 136 9: 997-1004. 2020

Partanen, Anu; Turunen, Antti; Valtola, Jaakko; Pyörälä, Marja; Vasala, Kaija; Kuittinen, Outi; Kuitunen, Hanne; Penttilä, Karri; Keskinen, Leena; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; Jantunen, Esa. 2020. Mobilization characteristics, blood graft composition, and outcome in diffuse large B-cell lymphoma after autologous stem cell transplantation: Results from the prospective multicenter GOA study Transfusion 2021; 61 2: 516-525. 2020

Partanen, A; Turunen, A; Valtola, J; Pyörälä, M; Vasala, K; Kuittinen, O; Kuitunen, H; Penttilä, K; Kuittinen, T; Mäntymaa, P; Pelkonen, J; Varmavuo, V Jantunen, E. 2020. Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34 + cells is associated with improved survival Leukemia & lymphoma 61 12: 3027-3029. 2020

Jantunen, Esa; Varmavuo, Ville; Pelkonen, Jukka; Valtola, Jaakko. 2019. Importance of early immune recovery after autologous hematopoietic cell transplantation in lymphoma patients Leukemia & lymphoma 60 9: 2115-2121. 2019

Rahkola, Dina; Laitala, Joel; Siiskonen, Hanna; Pelkonen, Jukka; Harvima, Ilkka T. 2019. Mast Cells Are a Marked Source for Complement C3 Products That Associate with Increased CD11b-Positive Cells in Keratinocyte Skin Carcinomas Cancer investigation 37 2: 73-84. 2019

Adem, Jemal; Eray, Mine; Eeva, Jonna; Nuutinen, Ulla; Pelkonen, Jukka. 2018. The combination of TRAIL and MG-132 induces apoptosis in both TRAIL-sensitive and TRAIL-resistant human follicular lymphoma cells Leukemia research 66: 57-65. 2018

Partanen, A; Valtola, J; Ropponen, A; Kuitunen, H; Kuittinen, O; Vasala, K; Ågren, L; Penttilä, K; Keskinen, L; Pyörälä, M; Nousiainen, T; Selander, T; Mäntymaa, P; Pelkonen, J; Varmavuo, V; Jantunen, E. 2018. Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients Transfusion 2019; 59 1: 325-334. 2018

Valtola, J; Silvennoinen, R; Ropponen, A; Siitonen, T; Säily, M; Sankelo, M; Putkonen, M; Partanen, A; Pyörälä, M; Savolainen, ER; Mäntymaa, P; Pelkonen, J; Jantunen, E; Varmavuo, V. 2018. Blood graft composition and post-transplant recovery in myeloma patients mobilized with plerixafor: a prospective multicenter study Leukemia & lymphoma 2019; 60 2: 453-461. 2018

Adem Jemal, Eray Mine, Eeva Jonna, Nuutinen Ulla, Pelkonen Jukka. 2017. Advantages of targeting B cell receptor complex to treat B-cell derived autoimmune diseases and lymphomas. MOLECULAR IMMUNOLOGY 88: 135-137. 2017

Adem Jemal, Eray Mine, Eeva Jonna, Nuutinen Ulla, Pelkonen Jukka. 2017. RIP1 has a role in CD40-mediated apoptosis in human follicular lymphoma cells. Immunobiology 222 11: 998-1003. 2017

Kaukinen Antti, Siiskonen Harri, Pelkonen Jukka, Harvima Ilkka T. 2017. Immunoreactivity to CYP24A1, but not vitamin D receptor, is increased in mast cells of keratinocyte skin cancers. EUROPEAN JOURNAL OF DERMATOLOGY 27 6: 590-598. 2017

Partanen A, Valtola J, Ropponen A, Vasala K, Penttilä K, Ågren L, Pyörälä M, Nousiainen T, Selander T, Mäntymaa P, Pelkonen J, Varmavuo V, Jantunen E. 2017. Preemptive plerixafor injection added to pegfilgrastim after chemotherapy in non-Hodgkin lymphoma patients mobilizing poorly. ANNALS OF HEMATOLOGY 96 11: 1897-1906. 2017

Partanen Anu, Valtola Jaakko, Silvennoinen Raija, Ropponen Antti, Siitonen Timo, Putkonen Mervi, Sankelo Marja, Pelkonen Jukka, Mäntymaa Pentti, Varmavuo Ville, Jantunen Esa. 2017. Impact of lenalidomide-based induction therapy on the mobilization of CD34+ cells, blood graft cellular composition, and post-transplant recovery in myeloma patients: a prospective multicenter study. Transfusion 57 10: 2366-2372. 2017

Haimakainen S, Kaukinen AP, Suttle M-M, Pelkonen J, Harvima IT. 2017. CD40 Ligand Is Increased in Mast Cells in Psoriasis and Actinic Keratosis but Less So in Epithelial Skin Carcinomas. Cancer Investigation 35 3: 143-151. 2017

Adem Jemal, Eraya Mine, Eeva Jonna, Nuutinen Ulla, Pelkonen Jukka. 2016. Timing determines dexamethasone and rituximab induced synergistic cell death. MOLECULAR IMMUNOLOGY 75: 200-202. 2016

Adem Jemal, Ropponen Antti, Eeva Jonna, Eray Mine, Nuutinen Ulla, Pelkonen Jukka. 2016. Differential Expression of Bcl-2 Family Proteins Determines the Sensitivity of Human Follicular Lymphoma Cells to Dexamethasone-mediated and Anti-BCR-mediated Apoptosis. Journal of Immunotherapy 39 1: 8-14. 2016

Valtola J, Silvennoinen R, Ropponen A, Siitonen T, Säily M, Sankelo M, Terävä V, Putkonen M, Kuittinen T, Pelkonen J, Mäntymaa P, Remes K, Varmavuo V, Jantunen E. 2016. Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison. Transfusion 56 6: 1394-1401. 2016

Valtola J, Varmavuo V, Ropponen A, Selander T, Kuittinen O, Kuitunen H, Keskinen L, Vasala K, Nousiainen T, Mäntymaa P, Pelkonen J, Jantunen E. 2016. Early immune recovery after autologous transplantation in non-Hodgkin lymphoma patients: predictive factors and clinical significance. LEUKEMIA & LYMPHOMA 57 9: 2025-2032. 2016

Valtola Jaakko, Varmavuo Ville, Ropponen Antti, Nihtinen Anne, Partanen Anu, Vasala Kaija, Lehtonen Päivi, Penttilä Karri, Pyörälä Marja, Kuittinen Taru, Silvennoinen Raija, Nousiainen Tapio, Pelkonen Jukka, Mäntymaa Pentti, Jantunen Esa. 2015. Blood graft cellular composition and posttransplant recovery in non-Hodgkin's lymphoma patients mobilized with or without plerixafor: A prospective comparison. Transfusion 55 10: 2358-2368. 2015

Toivonen Laura, Schuez-Havupalo Linnea, Rulli Maris, Ilonen Jorma, Pelkonen Jukka, Melen Krister, Julkunen Ilkka, Peltola Ville, Waris Matti. 2015. Blood MxA protein as a marker for respiratory virus infections in young children. JOURNAL OF CLINICAL VIROLOGY 62: 8-13. 2015

Kaukinen Antti, Pelkoonen Jukka, Harvima Ilkka T. 2015. Mast cells express CYP27A1 and CYP27B1 in epithelial skin cancers and psoriasis. EUROPEAN JOURNAL OF DERMATOLOGY [epub ahead of print]: -. 2015

Adem Jemal, Hämäläinen Aleksi, Ropponen Antti, Eeva Jonna, Eray Mine, Nuutinen Ulla, Pelkonen Jukka. 2015. ERK1/2 has an essential role in B cell receptor- and CD40-induced signaling in an in vitro model of germinal center B cell selection. MOLECULAR IMMUNOLOGY Volume 67, Issue 2, Part B: 240-247. 2015

Ademae Jemal, Ropponen Antti, Eeva Jonna, Eray Mine, Pelkonen Jukka, Nuutinen Ulla. 2015. Rituximab-induced early and late signaling have opposite effects on dexamethasone-induced apoptosis in human follicular lymphoma cells. LEUKEMIA & LYMPHOMA 56 8: 2448-2457. 2015

Barantsevich EP, Churkina IV, Barantsevich EP, Pelkonen J, Schlyakhto EV, Woodford N. 2013. Emergence of Klebsiella pneumoniae producing NDM-1 carbapenemase in Saint Petersburg, Russia. Journal of Antimicrobial Chemotherapy 68: 1204-6. 2013

Jantunen E, Ropponen A, Siitonen T, Niittyvuopio R, Sankelo M, Putkonen M, Varmavuo V, Pyörälä M, Kuittinen T, Silvennoinen R, Kutila A, Nihtinen A, Vasala K, Lehtonen P, Sikiö A, Valonen P, Nousiainen T, Pelkonen J, Mäntymaa P. 2013. Graft and outcome in autologous stem cell transplantation: a prospective GOA study. S532. 2013

Markkanen P, Pelkonen J, Mäki-Paakkanen J, Hirvonen M-R. 2011. Co-cultivated damp building related microbes trigger oxidative stress inducing cytotoxicity, DNA damage and inflammation in macrophages: Corsi, R.L. and Morrison, G., Indoor Air 2011. -. 2011

Diaconu Nicolae-Costin, Rummukainen Jaana, Naukkarinen Anita, Mättö Mikko, Harvima Rauno J, Pelkonen Jukka, Harvima Ilkka T.. 2011. Mast cell chymase is present in uterine cervical carcinoma and it detaches viable and growing cervical squamous carcinoma cells from substratum in vitro. ARCHIVES OF DERMATOLOGICAL RESEARCH 303 7: 499-512. 2011

Mitrofan LM, Castells FB, Pelkonen J & Mönkkönen J. 2010. Lysosomal-mitochondrial axis in zoledronic acid-induced apoptosis in human follicular lymphoma cells. JOURNAL OF BIOLOGICAL CHEMISTRY 285 3: 1967 - 1979. 2010

Nuutinen U, Ropponen A, Eeva J, Eray M, Pellinen R, Wahlfors J, Pelkonen J. 2009. The effect of microenvironmental CD40 signals on TRAIL- and drug-induced apoptosis in follicular lymphoma cells. SCANDINAVIAN JOURNAL OF IMMUNOLOGY 70 6: 565-573. 2009

Nuutinen U, Simelius N, Ropponen A, Eeva J, Mättö M, Eray M, Pellinen R, Wahlfors J, Pelkonen J. 2009. PDTC enables type I TRAIL signaling in type II follicular lymphoma cells LEUKEMIA RESEARCH 33: 829-836. 2009

Nuutinen U, Ropponen A, Suoranta S, Eeva J, Eray M, Pellinen R, Wahlfors J, Pelkonen J. 2009. Dexamethasone-induced apoptosis and up-regulation of Bim is dependent on glycogen synthase kinase-3 LEUKEMIA RESEARCH 33 12: 1714-1717. 2009

Mitrofan LM, Pelkonen J, Mönkkönen J. 2009. The level of ATP analog and isopentenyl pyrophosphate correlates with zoledronic acid-induced apoptosis in cancer cells in vitro. BONE 45: 1153-1160. 2009

Markkanen P, Pelkonen J, Tapanainen M, Mäki-Paakkanen J, Jalava PI, Hirvonen M-R.. 2009. Co-cultivated damp building related microbes Streptomyces californicus and Stachybotrys chartarum induce immunotoxic and genotoxic responses via oxidative stress INHALATION TOXICOLOGY 21: 857-867. 2009

Markkanen P, Pelkonen J, Tapanainen M, Mäki-Paakkanen J, Jalava PI, Hirvonen M-R. 2009. Co-cultivated damp building related microbes Streptomyces californicus and Stachybotrys chartarum induce immunotoxic and genotoxic responses via oxidative stress. INHALATION TOXICOLOGY 21 10: 857-867. 2009

Eeva J, Nuutinen U, Ropponen A, Mättö M, Eray M, Pellinen R, Wahlfors J, Pelkonen J. 2009. The involvement of mitochondria and the caspase-9 activation pathway in rituximab-induced apoptosis in FL cells. APOPTOSIS 14 5: 687-698. 2009

Mättö M, Raunio A-R, Postila V, Huttunen K, Hirvonen M-R, Pelkonen J. 2008. Human B cells and macrophages cooperate in T-cell-independent type 2 response SCANDINAVIAN JOURNAL OF IMMUNOLOGY 67: 209-217. 2008

Zemlin M, Schelonka RL, Ippolito GC, Zemlin C, Zhuang Y, Gartland GL, Nitschke L, Pelkonen J, Rajewsky K, Schroeder HW Jr.. 2008. Regulation of repertoire development through genetic control of Dh reading frame preference JOURNAL OF IMMUNOLOGY (BALTIMORE) 181: 8416-8424. 2008

Diaconu N-C, Rummukainen J, Mättö M, Naukkarinen A, Harvima RJ, Pelkonen J, Harvima IT. 2008. Cervical squamous carcinoma cells are resistant to the combined action of tumor necrosis factor-alpha and histamine whereas normal keratinocytes undergo cytolysis BMC CANCER [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCCANCER/] 8: [15, art. 46]. 2008

Eeva J, Ropponen A, Nuutinen U, Eeva S-T, Mättö M, Eray M. 2007. The CD40-induced protection against CD95-mediated apoptosis is associated with a rapid upregulation of anti-apoptotic c-FLIP. MOLECULAR IMMUNOLOGY 44: 1230-1237. 2007

Penttinen P, Tampio M, Mäki-Paakkanen J, Vähäkangas K, Pelkonen J, Hirvonen MR. 2007. DNA damage and p53 in RAW264.7 cells induced by the spores of co-cultivated Streptomyces californicus and Stachybotrys chartarum. TOXICOLOGY 235: 92-102. 2007

Skommer J, Wlodkowic D, Pelkonen J. 2007. CXCR4 expression during tumour cell death. LEUKEMIA RESEARCH 31 8: 1155-1156. 2007

Skommer J, Wlodkowic D, Pelkonen J. 2007. Gene-expression profiling during curcumin-induced apoptosis reveaös downregulation of CXCR4 EXPERIMENTAL HEMATOLOGY 35: 84-95. 2007

Wlodkowic D, Skommer J, Pelkonen J. 2007. Brefeldin a triggers apoptosis associated with mitochondrial breach and enhances HA14-1- and anti-Fas-mediated cell killing in follicular lymphoma cells. LEUKEMIA RESEARCH 31: 1687-1700. 2007

Wlodkowic D, Skommer J, Pelkonen J. 2007. Towards an understanding of apoptosis detection by SYTO dyes. CYTOMETRY. PART A 71A: 61-72. 2007

Skommer J, Wlodkowic D, Pelkonen J. 2006. Cellular foundation of curcumin-induced apoptosis in follicular lymphoma cell lines. EXPERIMENTAL HEMATOLOGY 34: 463-474. 2006

Wlodkowic D, Skommer J, Pelkonen J. 2006. Multiparametric analysis of HA14-1-induced apoptosis in follicular lymphoma cells. LEUKEMIA RESEARCH 30: 1187-1192. 2006

Nuutinen U, Postila V, Mättö M, Eeva J, Ropponen A, Eray M, Riikonen P, Pelkonen J. 2006. Inhibition of P13-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line EXPERIMENTAL CELL RESEARCH 312: 322-330. 2006

Skommer J, Wlodkowic D, Mättö M, Eray M, Pelkonen J. 2006. HA 14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells. LEUKEMIA RESEARCH 30: 322-331. 2006

Penttinen P, Pelkonen J, Huttunen K, Hirvonen M-R. 2006. Co-cultivation of Streptomyces californicus and Stachybotrys chartarum stimulates the production of cytostatic compound(s) with immunotoxic properties. TOXICOLOGY AND APPLIED PHARMACOLOGY 217: 342-351. 2006

Ippolito GC, Schelonka RL, Zemlin M, Ivanov II, Kobayashi R, Zemlin C, Cartland GL, Nitschke L, Pelkonen J, Fujihashi K, Rajewsky K, Shroeder Jr HW. 2006. Forced usage of positively charged amino acids in immunoglobulin CDR-H3 impairs B cell development and antibody production. JOURNAL OF EXPERIMENTAL MEDICINE 203 6: 1567-1578. 2006

Penttinen P, Huttunen K, Pelkonen J, Hirvonen M-R. 2005. The proportions of Streptomyces californicus and Stachybotrys chartarum in simultaneous exposure affect inflammatory responses in mouse. INHALATION TOXICOLOGY 17: 79-85. 2005

Penttinen P, Pelkonen J, Huttunen K, Toivola M, Hirvonen M-R. 2005. Interactions between Streptomyces californicus and Stachybotrys chartarum can induce apoptosis and cell cycle arrest in mouse RAW264.7 macrophages TOXICOLOGY AND APPLIED PHARMACOLOGY 202: 278-288. 2005

Mättö M, Nuutinen U-M, Ropponen A, Myllykangas K, Pelkonen J. 2005. CD45RA and RO isoforms have distinct effects on cytokine- and B-cell-receptor-mediated signalling in human B cells. SCANDINAVIAN JOURNAL OF IMMUNOLOGY 61: 520-528. 2005

Markkanen A, Penttinen P, Naarala J, Pelkonen J, Sihvonen A-P, Juutilainen J. 2004. Apoptosis induced by ultraviolet radiation is enhanced by amplitude modulated radiofrequency radiation in mutant yeast cells. BIOELECTROMAGNETICS 25 2: 127-133. 2004

Tuovinen L, Ruhanen E, Kinnarinen T, Rönkkö S, Pelkonen J, Urtti A, Peltonen S, Järvinen K. 2004. Starch acetate microparticles for drug delivery into retinal pigment epithelium - in vitro study JOURNAL OF CONTROLLED RELEASE 98: 407-413. 2004

Pitkänen L, Pelkonen J, Ruponen M, Rönkkö S, Urtti A. 2004. Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an vitro bovine eye model. AAPS JOURNAL [ONLINE:HTTP://WWW.AAPSPHARMSCI.ORG/] 6 3: 1-9. 2004

Huttunen K, Pelkonen J, Nielsen KF, Nuutinen U, Jussila J, Hirvonen M-R. 2004. Synergistic interaction in simultaneous exposure to Streptomyces californicus and Stachybotrys chartarum. ENVIRONMENTAL HEALTH PERSPECTIVES 112 6: 659-665. 2004

Harvima IT, Lappalainen K, Hirvonen MR, Matto M, Kivinen PK, Hyttinen M, Pelkonen J, Naukkarinen A. 2004. Heparin modulates the growth and adherence and augments the gowth-inhibitory action of TNF-alpha on cultured human keratinocytes. JOURNAL OF CELLULAR BIOCHEMISTRY 92 2: 372-386. 2004

Eeva J, Pelkonen J. 2004. Mechanisms of B cell receptor induced apoptosis. APOPTOSIS 9: 525-531. 2004

Pajusto M, Ihalainen N, Pelkonen J, Tarkkanen J, Mattila PS. 2004. Human in vivo-activated CD45R0+ CD4+ T cells are susceptible to spontaneous apoptosis that can be inhibited by the chemokine CXCL12 and IL-2, -6, -7, and -15. EUROPEAN JOURNAL OF IMMUNOLOGY 34: 2771-2780. 2004

Eeva J, Postila V, Mättö M, Nuutinen U, Ropponen A, Eray M, Pelkonen J. 2003. Kinetics and signaling requirements of CD40-mediated protection from B cell receptor-induced apoptosis. EUROPEAN JOURNAL OF IMMUNOLOGY 33: 2783-2791. 2003

Eray M, Postila V, Eeva J, Ripatti A, Karjalainen-Lindsberg M-L, Knuutila S, Andersson LC, Pelkonen J. 2003. Follicular lymphoma cell lines, an in vitro model for antigenic selection and cytokine-mediated growth regulation of germinal centre B cells. SCANDINAVIAN JOURNAL OF IMMUNOLOGY 57: 545-555. 2003

Ippolito GC, Pelkonen J, Nitschke L, Rajewsky K, Schroeder HW Jr. 2003. Antibody repertoire in a mouse with a simplified DH locus: the D-limited mouse. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 987: 262-265. 2003

Jumaa H, Bossaller L, Portugal K, Storch B, Lotz M, Flemming A, Schrappe M, Postila V, Riikonen P, Pelkonen J, Niemeyer C, Reth M. 2003. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia. NATURE (LONDON) 423: 452-456. 2003

Jussila J, Pelkonen J, Kosma V-M, Mäki-Paakkanen J, Komulainen H, Hirvonen M-R. 2003. Systemic immunoresponses in mice after repeated exposure of lungs to spores of Streptomyces californicus. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY 10 1: 30-37. 2003

Luosujärvi RA, Husman TM, Seuri M, Pietikäinen MA, Pollari P, Pelkonen J, Hujakka HT, Kaipiainen-Seppänen OA, Aho K. 2003. Joint symptoms and diseases associated with moisture damage in a health center CLINICAL RHEUMATOLOGY 22: 381-385. 2003

Ruponen M, Honkakoski P, Rönkkö S, Pelkonen J, Tammi M, Urtti A. 2003. Extracellular and intracellular barriers in non-viral gene delivery. JOURNAL OF CONTROLLED RELEASE 93: 213-217. 2003

Jussila J, Komulainen H, Kosma V-M, Pelkonen J, Hirvonen M-R. 2002. Inflammatory potential of the spores of Penicillium spinulosum isolated from indoor air of a moisture-damaged building in mouse lungs. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 12: 137-145. 2002

Rilla K, Lammi MJ, Sironen R, Törrönen K, Luukkonen M, Hascall VC, Midura RJ, Hyttinen M, Pelkonen J, Tammi M, Tammi R. 2002. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes JOURNAL OF CELL SCIENCE 115: 3633-3643. 2002

Jussila J, Komulainen H, Kosma V-M, Nevalainen A, Pelkonen J, Hirvonen M-R. 2002. Spores of Aspergillus versicolor isolated from indoor air of a moisture-damaged building provoke acute inflammation in mouse lungs. INHALATION TOXICOLOGY 14: 1261-1277. 2002

Jussila J, Komulainen H, Huttunen K, Roponen M, Iivanainen E, Torkko P, Kosma V-M, Pelkonen J, Hirvonen M-R. 2002. Mycobacterium terrae isolated from indoor air of a moisture-damaged building induces sustained biphasic inflammatory response in mouse lungs. ENVIRONMENTAL HEALTH PERSPECTIVES 110 11: 1119-1125. 2002

Eray M, Mättö M, Kaartinen M, Andersson LC, Pelkonen J. 2001. Flow cytometric analysis of apoptotic subpopulatios with a combination of Annexin V-FITC, propidium iodide, and SYTO 17. CYTOMETRY. PART A 43: 134-142. 2001

Jussila J, Komulainen H, Huttunen K, Roponen M, Hälinen A, Hyvärinen A, Kosma V-M, Pelkonen J, Hirvonen M-R. 2001. Inflammatory responses in mice after intratracheal instillation of spores of streptomyces californicus isolated from indoor air of a molby building. TOXICOLOGY AND APPLIED PHARMACOLOGY 171: 61-69. 2001

Liippo J, Nera K-P, Veistinen E, Lähdesmäki A, Postila V, Kimby E, Riikonen P, Hammarström L, Pelkonen J, Lassila O. 2001. Both normal and leukemic B lymphocytes express multiple isoforms of the human Aiolos gene. EUROPEAN JOURNAL OF IMMUNOLOGY 31 12: 3469-3474. 2001

Markkanen A, Juutilainen J, Lang S, Pelkonen J, Rytömaa T, Naarala J. 2001. Effects of 50 Hz magnetic field on cell cycle kinetics and the colony forming ability of budding yeast exposed to ultraviolet radiation. BIOELECTROMAGNETICS 22: 345-350. 2001

Nitschke L, Kestler J, Tallone T, Pelkonen S, Pelkonen J. 2001. Deletion of the DQ52 element within the Ig heavy chain locus leads to a selective reduction in VDJ recombination and altered D gene usage. JOURNAL OF IMMUNOLOGY (BALTIMORE) 166: 2540-2552. 2001

Ruponen M, Rönkkö S, Honkakoski P, Pelkonen J, Tammi M, Urtti A. 2001. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes. JOURNAL OF BIOLOGICAL CHEMISTRY 276 36: 33875-33880. 2001

Kröger L, Korppi M, Pelkonen J, Pietikäinen M, Katila M-L. 2000. Development of tuberculin reactivity and sensitization to M. Scrofulaceum and M. Fortuitum in children BCG-vaccinated at birth. EUROPEAN RESPIRATORY JOURNAL 15: 382-387. 2000

Perola O, Ripatti A, Pelkonen J. 2000. T-lymphocyte subpopulations do not express identical combinations of interleukin-2 receptor chains in the early phase of their activation and proliferation. SCANDINAVIAN JOURNAL OF IMMUNOLOGY 52: 123-130. 2000

Rytkönen-Nissinen M, Hurwitz JL, Pelkonen S, Levelt C, Pelkonen J. 1999. Early activation of TCR alpha gene rearrangement in fetal thymocytes. EUROPEAN JOURNAL OF IMMUNOLOGY 29: 2288-2296. 1999

Ackermann L, Harvima IT, Pelkonen J, Ritamäki-Salo V, Naukkarinen A, Harvima RJ, Horsmanheimo M. 1999. Mast cells in psoriatic skin are strongly positive for interferon-gamma. BRITISH JOURNAL OF DERMATOLOGY 140: 624-633. 1999

Ackermann L, Harvima I T, Pelkonen J, Ritamäki-salo V, Naukkarinen A, Harvima R J, Horsmanheimo M. 1999. Mast cells of psoriatic skin are strongly positive for interferon-gamma. BRITISH JOURNAL OF DERMATOLOGY 140: 624-633. 1999

Ackermann L, Pelkonen J, Harvima IT. 1998. Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1 IMMUNOLOGY 94: 247-252. 1998

Sareneva T, Matikainen S, Vanhatalo J, Melén K, Pelkonen J, Julkunen I. 1998. Kinetics of cytokine and NFAT gene expression in human interleukin-2-dependent T lymphoblasts stimulated via T-cell receptor. IMMUNOLOGY 93: 350-357. 1998

Mäntyjärvi R, Parkkinen S, Rytkönen M, Pentikäinen J, Pelkonen J, Rautiainen J, Zeiler T, Virtanen T. 1996. Complementary DNA cloning of the predominant allergen of bovine dander: A new member in the lipocalin family. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 97: 1297-1303. 1996

Rautiainen J, Pentikäinen J, Rytkönen M, Linnala-Kankkunen A, Pelkonen J, Virtanen T, Mäntyjärvi R. 1996. Molecular analysis of allergenic proteins in bovine dander. ALLERGY 51: 378-382. 1996

Rytkönen MA, Hurwitz JL, Thompson SD, Pelkonen J. 1996. Restricted onset of T cell receptor alfa gene rearrangement in fetal and neonatal thymocytes EUROPEAN JOURNAL OF IMMUNOLOGY 26: 1892-1896. 1996

Virtanen T, Zeiler T, Rautiainen J, Taivainen A, Pentikäinen J, Rytkönen M, Parkkinen S, Pelkonen J, Mäntyjärvi R. 1996. Immune reactivity of cow-asthmatic dairy farmers to the major allergen of cow (BDA20) and to other cow-derived proteins. The use of purified BDA20 increases the performance of diagnostic tests in respiratory cow allergy. CLINICAL AND EXPERIMENTAL ALLERGY 26: 188-196. 1996

Mäntyjärvi RA, Parkkinen S, Rytkönen M, Pentikäinen J, Pelkonen J, Rautiainen J, Zeiler T, Virtanen T. 1995. cDNA cloning and molecular characterization of bovine dander allergens. Teoksessa: Basomba A, Hernandez F. de Rojas (toim.), XVI European Congress of Allergology and Clinical Immunnlogy ECACI 95.Monduzzi. European Academy of Allergology and Clinical Immunology. ss. 111-115. 1995

Rautiainen J, Rytkönen M, Parkkinen S, Pentikäinen J, Linnala-Kankkunen A, Virtanen T, Pelkonen J, Mäntyjärvi R. 1995. cDNA cloning and protein analysis of a bovine dermal allergen with homology to psoriasin. JOURNAL OF INVESTIGATIVE DERMATOLOGY 105 5: 660-663. 1995

Rytkönen MA, Hurwitz J L.,Tolonen K & Pelkonen J. 1994. Evidence for recombinatorial hot spots at the T cell receptor Jalpha locus. EUROPEAN JOURNAL OF IMMUNOLOGY 24: 107-115. 1994

Pelkonen J, Palacios R. 1990. LD-1: A CD4-8-TCRab/CD3+ peripheral T cell line with helper function for B lymphocytes 2: 555-562. 1990

Thompson SD, Pelkonen J, Hurwitz JL. 1990. First T-cell receptor a gene rearrangements during T-cell ontogeny skew to the 5' region of the Ja locus. JOURNAL OF IMMUNOLOGY (BALTIMORE) 145: 2347-2352. 1990

Thompson SD, Pelkonen J, Rytkönen M, Samaridis J, Hurwitz JL. 1990. Non-random rearrangement of T-cell receptor J-alpha genes in bone marrow T-differentation cultures. JOURNAL OF IMMUNOLOGY (BALTIMORE) 144: 2829-2834. 1990

Yhteystiedot

Organisaatio

Sähköposti

Puhelin

TUTKIMUSRYHMÄT - UEF

Julkaisut